The impact of hepatitis B vaccine in China and in the China GAVI Project

Vaccine

Volumn 31, Issue S9, 2013, Pages

  Hadler, Stephen C ^a   Fuqiang, Cui ^b   Averhoff, Francisco ^c   Taylor, Thomas ^a   Fuzhen, Wang ^b   Li, Li ^b   Xiaofeng, Liang ^b   Weizhong, Yang ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

China; Hepatitis B; Laboratory diagnosis; Surveillance evaluation

Indexed keywords

HEPATITIS B VACCINE;

ACUTE HEPATITIS; ADOLESCENT; ARTICLE; CAUSE OF DEATH; CHILD; CHILD BEHAVIOR; CHILD HEALTH CARE; CHINA; FUNDING; GOVERNMENT; HEALTH CARE COST; HEALTH SURVEY; HEPATITIS B; HUMAN; INFANT; INFECTION PREVENTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MODEL; MORBIDITY; MORTALITY; POVERTY; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SCHOOL CHILD; SEROPREVALENCE;

CHINA; HEPATITIS B; LABORATORY DIAGNOSIS; SURVEILLANCE EVALUATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; INFANT; INFANT, NEWBORN; MALE; SURVIVAL ANALYSIS; VACCINATION;

EID: 84892410812     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.03.043     Document Type: Article

References (24)

1. Xia G.I., Liu C.B., Cao H.L., Bi S.L., Zhan M.Y., Su C.A., et al. Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D, and E virus infections in China. Int Hepatol Commun 1996, 5:62-73.
2. Zeng X.J., Yang G.H., Liao S.S., Chen A.P., Tan J., Huang Z.J., et al. Survey of coverage, strategy and cost of hepatitis B vaccination in rural and urban areas of China. World J Gastroenterol 1999, 5(4):320-323.
3. Goldstein S.T., Zhou F., Hadler S.C., Bell B.P., Mast E.E., Margolis H.S. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005, 34:1329-1339.
4. He J., Gu D.F., Wu X.G., Kristi R., Duan X.F., Yao C.H., et al. Major causes of death among men and women in China. N Engl J Med 2005, 353:1124-1134.
5. Perz J.F., Armstrong G.L., Farrington L.A., Hutin Y.J.F., Bell B. The contributions of heptitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006, 45:529-538.
6. Liang X.F., Bi S., Yang W., Wang L., Cui G., Cui F.Q., et al. Epidemiological serosurvey of Hepatitis B in China - declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009, 27:6550-6557.
7. Liang X.F., Cui F., Hadler S., Wang X., Chen Y., Kane M., et al. Origins, design and implementation of the China GAVI project. Vaccine 2013, 31:J8-J14.
8. Liang X.F., Bi S., Yang W., Wang L., Cui G., Cui F., et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis 2009, 200(1):39-47.
9. Yang W.Z., Liang X.F., Cui F.Q., et al. Key outcomes and addressing remaining challenges - perspectives from a final evaluation of the China GAVI project. Vaccine 2013, 31:J73-J78.
10. Cui F.Q., Luo H.M., Wang F.C., Zhong H., Gong X.H., Chen Y.S., et al. Evaluation of policies and practicies to prevent mother to child transmission of hepatitis B virus in China: results from GAVI final evaluation. Vaccine 2013, 31:J36-J42.
11. McMahon B.J., Bulkow L.R., Singleton R.J., Williams J., Snowball M., Homan C., et al. Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program. Hepatology 2011, 54:801-807.
12. Chang M.H., Chen J.C., Lei M.S., Hsu H.M., Wu T.C., Kong M.S., et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997, 336:1855-1859.
13. Ni Y.H., Huang L.M., Chang M.H.G., Yen C.J., Lu C.Y., You S.L., et al. Two decades of universal hepatitis B vaccination in Taiwan, impact and implication for future strategies. Gastroenterology 2007, 132:1287-1290.
14. Wichajarn K., Kosalaraksa P., Wiangnon S. Incidence of hepatocellular carcinoma in children in Khon Kaen before and after a national hepatitis B vaccine program. Asian Pac J Cancer Prev 2008, 9:507-510.
15. Viviani S., Carrieri P., Bah E., Hall A.J., Kirk G.D., Mendy M., et al. 20 years into the Gambia Hepatitis Intervention Study: assessment of initial hypothesis and prospects for evaluation of protective effectiveness against liver cancer. Cancer Epidemiol Biomarkers Prev 2008, 17(11):3216-3223.
16. MOH National review on national immunization programme in 2004. People Health Express 2005.
17. MOH Report of national expanded programme on immunization review in 2005 2004, 7-8.
18. d'Onofrio A., Manfredi P., Poletti P. The interplay of public intervention and private choices in determining the outcome of vaccination programmes. PLoS ONE 2012, 7(10):e45653. [Epub 01.10.12]. 10.1371/journal.pone.0045653.
19. Waissi G.R., Rossin D.F. A sigmoid approximation of the standard normal integral. Applied Mathematics and Computation 1996, 77(1):91-95.
20. National Bureau of Statistics Tabulation of the 2010 population census of People's Republic of China (Book 1). Compiled by population census office under the state council, Department of Population and Employment Statistics, National Bureau of Statistics April 2012, China Statistics Press, Beijing.
21. Cui F.Q., Li L., Hadler S.C., Wang F.Z., Hui Z., Chen Y.S., et al. Factors associated with effectiveness of the first dose of hepatitis B vaccine in China: 1992-2005. Vaccine 2010, 28:5973-5978.
22. Hu Y., Zhang S., Liu Q., Zhou Y.-H. Gaps in the prevention of perinatal transmission of hepatitis B virus between recommendations and routine practices in a highly endemic region: a provincial population-based study in China. BMC Infectious Diseases 2012, 12:221-233.
23. Fan C., Zhang B., Zhang L., Yvan H., Lei J., Tian J., et al. Injection safety assessments in two Chinese provinces, 2001-2009: progress and remaining challenges. Int Health 2012, 10.1016/j.inhe.2012.08.002.
24. Wu Z., Cui F., Chen Y., Miao N., Gong X., Luo H., et al. Evaluation of immunization injection safety in China 2010, achievements, future sustainability. Vaccine 2013, 31:J43-J48.